Thalidomide and Nail dystrophy - a phase IV clinical study of FDA data

Summary:

Nail dystrophy is reported as a side effect among people who take Thalidomide (thalidomide), especially for people who are female, 60+ old, also take Ativan, and have Muscle spasms.

The phase IV clinical study analyzes which people have Nail dystrophy when taking Thalidomide. It is created by eHealthMe based on reports of 16,470 people who have side effects when taking Thalidomide from the FDA, and is updated regularly.

What is Thalidomide?

Thalidomide has active ingredients of thalidomide. eHealthMe is studying from 16,473 Thalidomide users. Check the latest studies of Thalidomide.

What is Nail dystrophy?

Nail dystrophy (bed formation of nail) is found to be associated with 152 drugs and 289 conditions by eHealthMe. Check the latest studies of Nail dystrophy.



On Jun, 18, 2026

16,470 people reported to have side effects when taking Thalidomide.
Among them, 15 people (0.09%) have Nail dystrophy.

Could Thalidomide cause Nail dystrophy?

Among these 15 people:

What is the gender of people who have Nail dystrophy when taking Thalidomide? *

  • female: 53.33 %
  • male: 46.67 %

What is the age of people who have Nail dystrophy when taking Thalidomide? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 38.46 %
  • 60+: 61.54 %

What are other drugs people take besides Thalidomide? *

  1. Zometa: 15 people, 100.00%
  2. Aredia: 15 people, 100.00%
  3. Furosemide: 15 people, 100.00%
  4. Morphine Sulfate: 15 people, 100.00%
  5. Neurontin: 15 people, 100.00%
  6. Percocet: 15 people, 100.00%
  7. Gabapentin: 15 people, 100.00%
  8. Restoril: 15 people, 100.00%
  9. Ativan: 15 people, 100.00%
  10. Lorazepam: 14 people, 93.33%

What are other side effects people have besides Nail dystrophy? *

  1. Joint Pain: 15 people, 100.00%
  2. Spinal Osteoarthritis (joint cartilage loss in spine): 15 people, 100.00%
  3. Injury: 15 people, 100.00%
  4. Weight Increased: 15 people, 100.00%
  5. Osteonecrosis Of Jaw (death of bone of jaw): 15 people, 100.00%
  6. Pain: 15 people, 100.00%
  7. Pain In Extremity: 15 people, 100.00%
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 15 people, 100.00%
  9. Pneumonia: 15 people, 100.00%
  10. Cardiac Failure Congestive: 15 people, 100.00%

What are the existing conditions these people have? *

  1. Pain: 8 people, 53.33%
  2. Muscle Spasms (muscle contraction): 8 people, 53.33%
  3. Multiple Myeloma (cancer of the plasma cells): 7 people, 46.67%
  4. Pyogenic Liver Abscess (liver abscess caused by bacteria): 1 person, 6.67%
  5. Psoriasis (immune-mediated disease that affects the skin): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Thalidomide and have Nail dystrophy?

- Check whether Nail dystrophy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Thalidomide:

Nail dystrophy treatments and more:

How severe was Nail dystrophy and when was it recovered:

Expand to all the drugs that have ingredients of thalidomide:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Thalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nail dystrophy:

Browse all the conditions that are associated with Nail dystrophy:


How the study uses the data?

The study uses data from the FDA. It is based on thalidomide (the active ingredients of Thalidomide) and Thalidomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: